Literature DB >> 18929424

Identification of beta-1,4-galactosyltransferase I as a target gene of HBx-induced cell cycle progression of hepatoma cell.

Yuanyan Wei1, Dan Liu, Fengbiao Zhou, Yuqing Ge, Jiejie Xu, Xiaojing Yun, Jianxin Gu, Jianhai Jiang.   

Abstract

BACKGROUND/AIMS: The hepatitis B virus-encoded HBx protein contributes to hepatocarcinogenesis with largely unknown mechanisms. It is widely known that N-linked oligosaccharides on glycoproteins are structurally altered during malignant transformation and these alterations are often associated with malignant transformation of cells. beta-1,4-galactosyltransferase I (GalT I) contributes to the biosynthesis of Galbeta-->4GlcNAc structure in the outer chain moieties of N-glycans.
METHODS: The difference of GalT I expression between normal liver and hepatoma tissues were investigated; the effect of HBx on GalT I expression was investigated; the role of GalT I in hepatoma cell growth and HBx-induced hepatoma cell growth were investigated.
RESULTS: GalT I was highly expressed in hepatocellular carcinoma and transcriptionally up-regulated by HBx, and functioned as a positive growth regulator in hepatoma cells. Furthermore, decreasing the expression of GalT I in hepatoma cells reduced the ability of tumor formation in vivo and inhibited HBx-induced cell cycle progression.
CONCLUSIONS: HBx-induced GalT I expression might contribute to HBx-mediated HCC development and progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18929424     DOI: 10.1016/j.jhep.2008.09.003

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  12 in total

1.  The effects of HBx gene on the expression of DNA repair enzymes hOGG1 and hMYHalpha mRNA in HepG2 cells.

Authors:  Bin Cheng; Xiaorong Guo; Yaochu Zheng; Ying Wang; Chunyan Liu; Peiyuan Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-04-28

2.  Intermittent fasting from dawn to sunset for 30 consecutive days is associated with anticancer proteomic signature and upregulates key regulatory proteins of glucose and lipid metabolism, circadian clock, DNA repair, cytoskeleton remodeling, immune system and cognitive function in healthy subjects.

Authors:  Ayse L Mindikoglu; Mustafa M Abdulsada; Antrix Jain; Jong Min Choi; Prasun K Jalal; Sridevi Devaraj; Melissa P Mezzari; Joseph F Petrosino; Antone R Opekun; Sung Yun Jung
Journal:  J Proteomics       Date:  2020-01-09       Impact factor: 4.044

3.  Decreased expression of hepatocyte nuclear factor 4α (Hnf4α)/microRNA-122 (miR-122) axis in hepatitis B virus-associated hepatocellular carcinoma enhances potential oncogenic GALNT10 protein activity.

Authors:  Qian Wu; Hai-Ou Liu; Yi-Dong Liu; Wei-Si Liu; Deng Pan; Wei-Juan Zhang; Liu Yang; Qiang Fu; Jie-Jie Xu; Jian-Xin Gu
Journal:  J Biol Chem       Date:  2014-11-24       Impact factor: 5.157

4.  Ribosomal RACK1 promotes chemoresistance and growth in human hepatocellular carcinoma.

Authors:  Yuanyuan Ruan; Linlin Sun; Yuqing Hao; Lijing Wang; Jiejie Xu; Wen Zhang; Jianhui Xie; Liang Guo; Lei Zhou; Xiaojing Yun; Hongguang Zhu; Aiguo Shen; Jianxin Gu
Journal:  J Clin Invest       Date:  2012-06-01       Impact factor: 14.808

5.  Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cells.

Authors:  Caroline Bret; Dirk Hose; Thierry Reme; Anne-Catherine Sprynski; Karène Mahtouk; Jean-François Schved; Philippe Quittet; Jean-François Rossi; Hartmut Goldschmidt; Bernard Klein
Journal:  Br J Haematol       Date:  2009-03-02       Impact factor: 6.998

6.  Knockdown of HBx by RNAi inhibits proliferation and enhances chemotherapy-induced apoptosis in hepatocellular carcinoma cells.

Authors:  Yan He; Hui-qing Sun; Xing-e He; Wen-long Wang; Jian-hua Lei
Journal:  Med Oncol       Date:  2009-12-01       Impact factor: 3.064

7.  Tripartite Motif Containing 52 (TRIM52) Promotes Cell Proliferation in Hepatitis B Virus-Associated Hepatocellular Carcinoma.

Authors:  Yi Zhang; Shan-Shan Wu; Xiao-Hua Chen; Zheng-Hao Tang; Yong-Sheng Yu; Guo-Qing Zang
Journal:  Med Sci Monit       Date:  2017-11-01

8.  B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients.

Authors:  Huyang Xie; Yu Zhu; Junyu Zhang; Zheng Liu; Hangcheng Fu; Yifan Cao; Gaoxiang Li; Yijun Shen; Bo Dai; Jiejie Xu; Dingwei Ye
Journal:  BMC Cancer       Date:  2018-05-24       Impact factor: 4.430

9.  C1GALT1 promotes invasive phenotypes of hepatocellular carcinoma cells by modulating integrin β1 glycosylation and activity.

Authors:  Chiung-Hui Liu; Rey-Heng Hu; Miao-Juei Huang; I-Rue Lai; Chia-Hua Chen; Hong-Shiee Lai; Yao-Ming Wu; Min-Chuan Huang
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

10.  Increased B4GALT1 expression associates with adverse outcome in patients with non-metastatic clear cell renal cell carcinoma.

Authors:  Huyang Xie; Yu Zhu; Huimin An; Hongkai Wang; Yao Zhu; Hangcheng Fu; Zewei Wang; Qiang Fu; Jiejie Xu; Dingwei Ye
Journal:  Oncotarget       Date:  2016-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.